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AP-2αDefects in closure of embryonic tissues such as the neural tube, body wall, face and eye lead to severe birth
defects. Cell adhesion is hypothesized to contribute to closure of the neural tube and body wall; however,
potential molecular regulators of this process have not been identiﬁed. Here we identify an ENU-induced
mutation inmice that reveals amolecular pathway of embryonic closure. Line2F homozygousmutant embryos
fail to close the neural tube, body wall, face, and optic ﬁssure, and they also display defects in lung and heart
development. Using a new technology of genomic sequence capture and high-throughput sequencing of a
2.5 Mb region of the mouse genome, we discovered a mutation in the grainyhead-like 2 gene (Grhl2).
Microarray analysis revealed Grhl2 affects the expression of a battery of genes involved in cell adhesion and E-
cadherin protein is drastically reduced in tissues that require Grhl2 function. The tissue closure defects in Grhl2
mutants are similar to that of AP-2α null mutants and AP-2α has been shown to bind to the promoter of E-
cadherin. Therefore, we tested for a possible interaction between these genes. However, we ﬁnd that Grhl2 and
AP-2αdonot regulate each other's expression, E-cadherin expression is normal inAP-2αmutants during neural
tube closure, and Grhl2;AP-2α trans-heterozygous embryos are morphologically normal. Taken together, our
studies point to a complex regulation of neural tube fusion and highlight the importance of comparisons
between these two models to understand more fully the molecular pathways of embryonic tissue closure.RC1 South, Room L18-12400,
1 303 724 3792.
swander).
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Neurulation, the process that gives rise to the central nervous
system, in mammals is a complex and highly dynamic morphogenetic
process during which the ﬂat neural plate rolls up and closes to form
the neural tube. Neurulation occurs in at least four distinct steps,
namely thickening of the ectoderm to form a ﬂat neural plate,
elevation of the lateral edges of the neural plate to form the neural
folds, apposition of the neural folds, and ﬁnally, joining of the neural
folds in the midline. This last step includes separation of the neural
ectoderm from the non-neural ectoderm and closing of these tissues
to form the neural tube covered by a single layer of ectoderm. This
ﬁnal closure event has traditionally been called fusion, although the
cells do not actually fuse. Neural tube defects (NTD) or failure of
neural tube closure occurs in ~1:1000 live human births. Studies in
mice have lent considerable insight into the genetics of neural tube
closure and have identiﬁed genes involved in processes including
neural patterning, cell proliferation, and tissue architecture; however,
relatively little is known about the molecular basis of fusion of the
neural folds (Harris and Juriloff, 2010). Other embryonic tissues alsoundergo closure events and it has been proposed that similar
mechanisms of fusion are utilized. Body wall closure occurs when
the lateral edges of the embryonic ectoderm andmesoderm are joined
and fuse at the ventral midline. Defective bodywall closure can lead to
an open abdominal and/or thoracic cavity. Closure of the optic ﬁssure
occurs through joining of the folds of the optic cup, disruption of
which results in coloboma. Finally, the facial prominences also
undergo fusion and defects in facial closure can result in birth defects
ranging from cleft lip and palate to clefting of the entire face. Although
birth defects due to failure of closure of embryonic tissues are of
considerable medical consequence, the cellular and molecular events
that regulate fusion remain unknown.
It has been long hypothesized that fusion relies on adhesion
molecules for its completion. Although this is a compelling idea, the
molecules that regulate the process of neural tube, body wall or optic
ﬁssure closure are not well deﬁned. With respect to neural tube
closure, mutations in adhesion molecules, such as EphrinA5 and
EphA7, can cause NTD in mice (Holmberg et al., 2000), although
neither has been shown to be directly involved in the step of neural
fold fusion. Cadherins are also thought to be predominant cell
adhesion molecules involved in initial recognition and formation of
cell–cell interactions between the juxtaposed neural folds during
mammalian neural tube formation. Two observations that support
this hypothesis are different subtypes of cadherins control various
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cadherins are essential for neurulation in a number of animal models,
including Xenopus (Rashid et al., 2006) and mice (Chen and Hales,
1995). However, the details of their function and what step of
neurulation these molecules control are not fully understood. No
speciﬁc adhesion molecules are yet implicated in closure of the body
wall. The AP-2α null mouse is one example of a gene mutation that
causes defects in body wall and neural tube closure (Brewer and
Williams, 2004; Nottoli et al., 1998). In cancer cell lines, AP-2α has
been shown to bind the promoter of E-cadherin and the functional
consequences of this have been studied in adult tissues and cancer
cells (Baldi et al., 2001; Schwartz et al., 2007). The relationship
between AP-2α and E-cadherin in the embryo has only been explored
in the cornea of the developing eye (West-Mays et al., 2003).
Here we describe the identiﬁcation of an ENU-induced nonsense
mutation in the grainyhead-like 2 (Grhl2) gene that encodes a
transcription factor. This mutation reveals the requirement for
Grhl2 in closure of embryonic tissues as Grhl2 mutants display
cranial NTD (exencephaly), cleft face, body wall closure defect
(thoracoabdominoschisis), and defective optic ﬁssure closure
(coloboma). Moreover, Grhl2 is required in other tissues as mutant
embryos display lung and heart defects, soft tissue syndactyly, and
molecular changes in the skin and hair follicle. Microarray analysis
comparing wildtype and mutant cranial tissue reveals changes in a
number of genes that encode proteins involved in cell adhesion.
Immunohistochemical analysis demonstrates a dramatic reduction in E-
cadherin expression in mutant tissues, corresponding to where Grhl2
would normally be expressed. Moreover, we explore the relationship
between the Grhl2 and AP-2α transcription factors during neural tube
closure. Despite the similar fusion defects, Grhl2 and AP-2α do not
regulate one another's transcription and AP-2α is not required for E-
cadherin protein expression. Thus, comparisons between these two
models will be important in uncovering the molecular complexity that
underlies the regulation of key embryonic closure events.
Materials and methods
Generation of Line2F embryos and genetic mapping
The Line2F mutation was induced with the chemical mutagen
ethyl nitrosourea (ENU) on a C57BL/6J genetic background. Originally,
the line was outcrossed to C3HeB/FeJ and later outcrossed to 129S1/
SvImJ (129) for 7 generations. Meiotic mapping placed the Line2F
mutation onmouse chromosome 15 between initial markers D15Mit8
(33,393,085 bp) and D15mit138 (39,861,164 bp) and was further
deﬁned by D15Am33.45A (forward primer CGT CTA GAG GCA CTG
TGA GG, reverse primer TTT CCC TGG AAA CAC TAA GTCAA). This
marker lies at 36,643,830 bp and the number of recombination events
over the number of opportunities for recombination was 2/50.
Markers that were also used to further deﬁne the region were:
D15MIT49 (37,204,637 bp; 0/170), D15MIT6 (38,474,396; 17/207),
and FA6 (39,430,000; 25/207) forward primer TCC AAA CTG TTT TAA
AGG CAA A, reverse primer CAA CTT GAA TAT TGT ATG CAT CTC C).
Heterozygous carriers were mated and the embryonic stage was
determined considering noon of the day of a vaginal plug as E0.5. At
dissection, the embryonic phenotype was recorded and a small
portion of the embryo or yolk sac removed for genotyping. Embryos
were ﬁxed in 4% paraformaldehyde (PFA) overnight and then
processed for whole mount or section (10 μm) in situ hybridization
or for immunohistochemistry.
Sequence capture and 454 sequencing
A targeted sequence capture strategy was used to preferentially
enrich for and subsequently sequence the critical genomic region
containing the Line2F mutation to identify the genetic basis of themutant phenotype. Roche-Nimblegen custom-designed hybrid cap-
ture microarray chip with 385,000 spotted oligonucleotides was used
to capture and enrich for the region of interest. Based on the C57BL/6
mouse reference genome sequence, oligonucleotides were designed
by Roche-Nimblegen that covered the 36.0–38.5 Mb target region on
mouse chromosome 15 but avoided repetitive element sequences.
After the initial design phase, we slightly lowered the stringency of
exclusion of repeat elements so that coverage of more genic and
intergenic regions would be provided by the tiling scheme.
For DNA preparation, E10.5 embryos from a heterozygous cross
were dissected and the yolk sac used to determine the genotype. Three
homozygousmutant embryos from the same litter were homogenized
with a handheld mechanical homogenizer. DNA extraction was
performed using Qiagen DNA extraction kit (cat#69581), which
yielded ~10 μg of DNA from three E10.5 embryos. These embryos
were homozygous for any potential mutations within this 2.5 Mb
region and this region would derive from C57BL/6J. Nimblegen
processed the genomic DNA using fragmentation by nebulization,
size selection, end-repair, and linker addition to the ends. This
genomic library was then hybridized to the custom-designed
hybridizationmicroarray chip using the standardNimblegen sequence
capture protocol. In brief, this protocol (conducted by Nimblegen)
involved hybridization to the chip, washing away non-hybridized
sequences, elution of hybridized library from the chip, and evaluation
of enrichment via qPCR. The resulting enriched library was further
processed to be compatible with 454 sequencing by ligation of 454-
speciﬁc adapters and selection with beads for the correct compliment
of adapters. The enriched librarywas sequenced by the Consortium for
Comparative Genomics at the University of Colorado Denver using FLX
emulsion PCR kit 1. Enriched emulsion PCR beads were sequenced on
the 454GS-FLX sequencer using 70×75cmsequencingplates and FLX-
LR sequencing reagents. All emulsion PCR, bead enrichment, and
sequencing methods strictly adhered to default 454-provided
protocols.
Analysis of sequencing results
The data were analyzed using the 454 GS-mapper software by the
Consortium for Comparative Genomics at the University of Colorado
Denver with assistance by V. Vemulapali. The targeted region of the
mouse genome from C57BL/6 strain was downloaded from the UCSC
browser and used as a reference for mapping of 454 sequence reads.
Default parameters were used for 454 GS-mapper software analyses.
Approximately 80% of the sequence obtained from the enriched library
mapped back to the region of interest. The GS-mapper produced a ﬁle
with the details of high quality mutations, and this ﬁle was further
processed and summarized using a Perl script. Because our source
genomicDNAwasexpected to behomozygous for anymutationswithin
the targeted region, the Perl script ﬁltered out putative mutations at
sites where at least one read matched the reference sequence.
Sequencing data from the 454 GS-FLX sequencer were aligned with
the published C57BL/6 sequence using the 454 sequencer software to
generate a list with nucleotides that differed in the mutant DNA
(referred to as SNPs). Further analysis of the SNPs was done through
Ensembl (http://uswest.ensembl.org/Mus_musculus/Info/Index) and
the Expasy translation engine (http://www.expasy.ch/tools/dna.html)
to determine the effect of the nucleotide change on predicted proteins
and potential regulatory elements.
These analyses identiﬁed a SNP in the coding region of Grhl2
predicted to create a stop codon. To verify this result, DNA from 4
mutant and 4 wildtype embryos was extracted using Qiagen DNA
extraction kit (cat#69581). A 400-nucleotide region around position
37,200,529 bp on chromosome 15 was PCR ampliﬁed with custom-
designed primers (sequencing forward: AAA GAC TAG TGG CCT TAG
TGC CCA; sequencing reverse: CTC GGT GAT GGA TAC ACT GTA CTG
CT). Sequencing of the 400 nucleotide region was performed at the
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same custom primers.
For genotyping of carrier animals and embryos, the Grhl21Nisw
mutation was speciﬁcally detected using ARMS primers according to
Ye et al. (2001): Outer primer 1: TAG TGG CCT TAG TGC CCA TGC CCA
GTG; outer primer 2: TGA AGT TGG GTT TCA CAA GGG GGG AGG; A
allele primer: CTG CCG CCC TGGGCC TGC TCA AA; T allele primer: CCA
AGG GAG AGC CCA CCT TGT AGT AGA CA.Microarray and data analysis
E9.5mouseembryos (23–25 somites)were collected and tissue from
the head above the ﬁrst branchial arch was dissected, frozen in dry ice
and stored at−80 °C, while the remainder of the embryo was used for
genotyping to distinguish mutant from wildtype. Tissue from eight
homozygous mutant and eight homozygous wild type embryos from
four different litters was collected and then processed at the same time
for consistency purposes. RNA was extracted using RNA-easy micro kit
(Qiagen) and kept at−80 °C until use.
RNA ampliﬁcation, labeling and hybridization for the microarray
experiment were performed according to the Affymetrix protocol as
described in the user manual GeneChip®Whole Transcript (WT)
Sense Target Labeling Assay, and the microarray chip used for the
hybridization was from Affymetrix Mouse Gene 1.0 ST version 1. The
microarray experiments were conducted by the University of
Colorado Denver Microarray Core Facility.
Analysis of the microarray data was performed in collaboration
with T. Shade from the UC Denver microarray core. All available raw
gene expression data (probe-level) from Affymetrix CEL ﬁles was
imported into Partek Genomics Suite (version 6.4, build 6.08.1010,
copyright 1993–2008, Partek Inc., St. Louis, MO, USA) software for
data analysis, i.e. Pre-background Adjustment, Background Correc-
tion, Normalization, and Summarization. Principal Component Anal-
ysis (PCA) was performed on the normalized data to identify any
outlier samples. Prior to performing statistical analysis, the control
probes were ﬁltered out, leaving only the interrogating probes. No
other ﬁltering was performed on the dataset prior to performing the
analysis of variance (ANOVA) to determine statistically signiﬁcant
gene regulation between the two experimental groups. The data was
log base 2 (log2) transformed prior to running the ANOVA. After the
ANOVA, the log2 ratios were converted into a linear scale fold change.
p-values were calculated determining themost statistically signiﬁcant
gene changes. The dataset was then limited to geneswith fold changes
higher than 1.25 to observe the most robust up- and downregulated
genes for the two experimental groups.
Tissue for quantitative real-time PCR was collected and RNA was
prepared as for the microarray experiment (see above). cDNA was
made with the use of SuperScript III ﬁrst strand kit (Invitrogen cat#
18080–051) and qRT-PCR was performed with TaqMan probe-based
gene expression analysis, using primers commercially available from
Applied Bioscience.RNA in situ hybridization and immunoﬂuorescence
Whole-mount and section RNA in situ were performed as
described (Holmes and Niswander, 2001; Liu et al., 1998). Immuno-
histochemistry on cryosections was performed as described (Kim
et al., 2007). Antibodies: Islet1 (Developmental Studies Hybridoma
Bank 39.4D5; dilution 1:100), TuJ1 (Covance cat# MMS-435P;
dilution 1:1000), phospho-Histone3 (Cell Signaling cat#9701-S;
dilution 1:200), E-cadherin and Ezrin (Transduction Laboratories;
both at 1:100), Beta-catenin (Santa Cruz biotechnology; 1:50).
Immunoﬂuorescence was visualized with LSM510 META confocal
microscope from Zeiss.Proliferation
Transverse cryosections at the level of the rostral spinal cord/
caudal hindbrain from E8.5, E9.5 and E10.5 mutant and wild type
embryos were stained with antibodies against phospho-Histone3
(1:200 dilution), phalloidin (1:400), and Hoechst (1:1000). Five
embryos from each age and ~6 sections/embryo were used for cell
counting. The number of dividing cells in the neural tube of each
section, as determined by the presence of phospho-Histone3 staining,
was divided by the number of total cells in the neural tube per section
as determined by the Hoechst nuclear stain to quantify the percentage
of proliferating cells/total cells in each section. The average of this
ratio was compared using unpaired two-tailed Student's t-test
between mutant and wild type. For all three ages, such a comparison
lead to non-signiﬁcant p-valueN0.05.
Results
Genomic sequence capture and high-throughput sequencing identify
Grhl2 mutation in Line2F embryos with defective tissue closure
Using ENU mutagenesis and a three-generation forward genetic
screen as an unbiased approach to identify recessive genes that are
critically required for neural tube closure, we identiﬁed Line2F. As
described in the next section, Line2F homozygous mutant embryos
displayed abnormalities in many tissues including failure to close the
neural tube, face, body wall, and optic ﬁssure, as well as soft tissue
syndactyly, lung and heart defects. To identify the ENU-induced
mutation, we used meiotic recombination mapping to determine
association between the mutant phenotype and the C57BL/6J genetic
background on which the mutation was generated. This deﬁned the
Line2F mutation to a less than 2 Mb region on chromosome 15
between 36.64 and 38.51 Mb.Within this interval are 11 transcription
units, as listed in Supplemental Table 1, of which one is a predicted
gene and the null phenotype of four other genes are not compatible
with the Line2F phenotype as they die later than Line2F mutants and
they do not have NTD (An et al., 2010; Kimura et al., 2003; Wan et al.,
2010; Zhou et al., 2007).
The traditional approach to identify the causative mutation
induced by ENU mutagenesis has been high-resolution mapping,
followed by ampliﬁcation and sequencing of coding regions and splice
junctions of genes in the interval. Although the current positional
cloning process is relatively straightforward, it does require expertise
in mouse genetics, ample vivarium space and considerable genotyp-
ing, which translate to high cost. Moreover, the process is labor
intensive since it relies on PCR ampliﬁcation of large numbers of
individual templates that are then sequenced, further adding to the
cost, in particular if the critical region is gene-rich and/or has no
obvious candidate genes. Furthermore, traditional sequencing for
mutations in genes in the interval or exome sequencing focus on
sequencing of coding sequences and splice junctions and hence may
be fruitless if the mutation lies in noncoding sequence or sequence
that is not well annotated.
Here we used a new technology of genomic sequence capture
followed by high-throughput sequencing to identify in an unbiased
way the ENU-induced mutation(s) throughout this interval, including
in regulatory elements and sequences between genes or exons. Using
this approach, all potential mutations within a candidate region as
large as 5 Mb can be found in a few months. Thus, sequence capture
technology can signiﬁcantly reduce the time and resources required
for mutation identiﬁcation because it eliminates the need for high-
resolution genetic mapping, long-range PCR, and sequencing of
individual PCR amplimers. The sequence capture approach has been
previously used to amplify a 200 kilobase region in order to identify
novel alleles in mutant models of the Kit locus (D'Ascenzo et al.,
2009). In our study, we used this technique for the ﬁrst time to
Fig. 1. Sequence capture identiﬁes Grhl2 mutation in Line2F. Sequence capture to enrich for genomic sequences from 36.0 to 38.5 Mb on mouse chromosome 15 followed by high-
throughput sequencing identiﬁed (A) SNP178 in which all reads from homozygous mutant DNA show a consistent change from T to A (red asterisk) that differs from the publically
available C57BL/6 sequence. This is predicted to lead to an early stop codon in the Grhl2 gene. (B) Veriﬁcation of the base change was done by PCR ampliﬁcation of 400 bp of Grhl2
from DNA fromwildtype (top) andmutant (bottom) embryos followed by Sanger sequencing. The chromatogram shows the T (red arrow) to A (red asterisk) nucleotide change. (C)
Schematic of Grhl2 protein. The Grhl21Nisw mutation is predicted to truncate the protein 52 amino acids from the N-terminus of the protein and to delete the CP2 DNA binding
domain.
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genome. We captured a region that was ~12.5 times greater to
identify the causative ENU-induced mutation in Line2F.
As described in more detail in the Materials and methods section,
closely spaced probes that targeted unique sequences between 36.0
and 38.5 Mb on mouse chromosome 15 were designed by Roche-
Nimblegen and placed on a microchip. Genomic DNA was extracted
from homozygous mutant embryos, fragmented, and hybridized to
the custom primer array to enrich for this 2.5 Mb region. Approxi-
mately 80% of the recovered DNA mapped back to the region of
interest, demonstrating successful enrichment. The enriched DNAwas
sequenced using 454 GS-FLX sequencing to ~20X coverage. Compar-
ative analysis of these sequences against themouse C57BL/6 reference
genome showed only one single mutation, SNP178, that altered the
amino acid translation of a coding region. SNP178was consistent in all
seven reads from the mutant embryo and there were no other reads
(Fig. 1A).
SNP178 represented a T to A transversion at position 37,200,529
on chromosome 15 within the coding region of the gene grainyhead-
like 2, Grhl2. This mutation was veriﬁed by using locus-speciﬁc
primers to PCR amplify a 400 bp fragment from four wildtype and four
mutant embryos followed by Sanger sequencing using the same
custom primers (Fig. 1B). This change in the mutant is predicted to
introduce a premature stop codon at amino acid 52, and hence delete
573 amino acids from the predicted 625 amino acid protein normally
encoded by Grhl2, including the predicted CP2 DNA binding domain
(Fig. 1C) (Tuckﬁeld et al., 2002). This allele will be called Grhl21Nisw.
The founding member of the Grhl family of transcription factors is
Drosophila grainyhead (also calledNTF-1 or Elf-1). The ﬁvemammalian
Grhl familymembers form two distinct phylogenetic groups according
to sequence alignment (Wilanowski et al., 2002). The ﬁrst group
consists of CP2, LBP-1a and LBP-9 genes, which are widely expressed
and have diverse functions in T-cell proliferation, globin gene
expression and steroid biosynthesis (Volker et al., 1997; Zhou et al.,
2000). The second group consists of Mammalian Grainyhead or Grhl1,
Brother-of-MGR or Grhl2, and Sister-of-MGR or Grhl3 (Ting et al.,
2003b; Wilanowski et al., 2002). Grhl1 null mutations have defective
hair growth (Wilanowski et al., 2002). Grhl3 null mutants display
100% penetrant spina biﬁda and ~3% exencephaly (Ting et al., 2003b).
Grhl2mutations are associated with hearing loss in humans (Van Laer
et al., 2008). There have been two recent reports of mutations in Grhl2
in mice leading to exencephaly and split face (targeted allele, Rifat
et al., 2010; gene-trap alleles, Werth et al., 2010), similar to thephenotype discussed below for Line2Fmutants. Althoughwe have not
provided deﬁnitive proof that the mutation in Grhl2 is causative for
the Line2F phenotype, such as non-complementation in a genetic
cross with another Grhl2 allele, we present strong evidence that
suggests that it is a mutation in Grhl2 that causes the Line2F
phenotype. This includes meiotic mapping of the critical interval in
Line2F to less than 2 Mb, and sequencing of this entire region, plus
another 0.5 Mb of ﬂanking DNA, which showed the only mutation in a
coding region was in the Grhl2 gene and this is predicted to lead to
severe truncation of the Grhl2 protein. Moreover, presence of NTD and
loss of E-cadherin expression (see below) in both the gene-trap Grhl2
mutants and the ENU-induced Grhl2 mutant, lend strong support to
the idea that the Grhl2 mutation is responsible for the phenotype in
Line2F.
Grhl21Nisw embryos show a general defect in closure of embryonic tissues
The ENU-induced Grhl21Niswmutationwas produced on a C57BL/6J
genetic background. All of the analyses here were conducted on
animals bred into 129S1/SvImJ (129) background for seven genera-
tions, except for the skeletal stainings, which were done on C3HeB/FeJ
(C3H) background. On a 129 background, Grhl21Nisw/1Nisw embryos
display complete exencephaly (hindbrain, midbrain, forebrain) and
cleft face (100%)wherein the upper jaw (maxilla,mx) and upper part of
the face fail to close (Fig. 2B, D and F compared to wild type in Fig. 2A, C
and E), but the lower jaw (mandible, m) is formed (Fig. 2B;
Supplemental Fig. 1A and B). Primary thoracoabdominoschisis is also
observed (100% of the embryos that survive to E12.5 or later) exposing
the organs within the thorax and abdomen to the uterine environment
due to failure of bodywall closure (Fig. 2B, Supplemental Fig. 1B). There
is a high percentage of embryonic lethality at embryonic day E9.5 and
only a few embryos (~5%) survive past that age. A small percentage
(~5%) of mutant embryos displayed a more severe phenotype being
signiﬁcantly smaller than littermates, developmentally delayed and
unturned, with open “wavy” neural folds (Supplemental Fig. 1C).
Further outcrossing into 129 background increased the percentage
of non-maintained pregnancies. Dissections of pregnant females later
than E10.5 days (N5 generations outcross to 129) yielded small litters
of approximately 2–3 embryos and a high number of resorptions (~3–
6 resorbed embryos per litter). Based onMendelian inheritance, this is
a greater number than expected for loss of homozygous mutants, and
hence suggests an additional defect, perhaps loss of heterozygous
embryos or overall fetal loss perhaps due to a maternal defect.
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phaly (100%), bodywall defects (50%), cleft face or unilateral or bilateral
cleft (100% in total) and soft tissue syndactyly (webbing between the
digits, ~7%) and a proportion of these embryos survived to E18.5.
Skeletal stainings of E18.5 mutant embryos showed lack of skeletal
components of the top of the skull andmidface (compare Fig. 2L, N to K,M) whereas the lower jaw and ventral skull were present (Fig. 2O and
P). In themutant thorax, the ribs attached to the sternumbut the left and
right sides of the sternum failed to connect in the midline to form one
continuous bone (Fig. 2Q and R). Grhl21Nisw mutants also displayed eye
defects that resemble the human condition called coloboma, wherein
the edges of the optic ﬁssure fail to close, leaving a gap in the iris
Table 1
Gene expression tested by qRT-PCR.
Gene
symbol
Fold-change p-value
(mutant vs. WT) (mutant vs. WT)
1 Rab25 –23.28 0.0231
2 EpCam –6.09 0.0463
3 Esrp1 –4.33 0.0151
4 E-cdh –4.00 0.0003
5 Txnip –2.54 0.0222
6 Rab15 –2.35 0.0234
7 Dsp –2.18 0.0332
8 Grhl2 –2.17 0.0051
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neural folds, craniofacial structures, bodywall and opticﬁssure suggests
thatGrhl21Niswmutants have a defect in the process of embryonic tissue
fusion.
The neural tube closure defect in Grhl21Nisw is evident as early as
E9.5 in that the neural folds had elevated normally and the folds were
juxtaposed but not fused (Fig. 2G and H). This was not due to
developmental delay by comparing somite-matched littermates and
as dissection at later stages showed no evidence of closure. Bending of
the neural folds appeared normal and histological sections show
formation of the medial and dorsolateral hinge points in the mutant
(Fig. 2I and J). Similarly, there is normal craniofacial growth and
juxtaposition of the facial prominences at the midline but failure to
close (Fig. 2E and F). These results differ from a recent report that
described a targeted deletion in Grhl2 in which these embryos
displayed a broadly open cranial neural tube that lacked dorsolateral
hinge points and had minimal bending at the medial hinge point
(Rifat et al., 2010). Additional phenotypic differences between the
targeted mutation and the ENU Grhl21Nisw allele (on C57BL/6 and129
backgrounds, respectively) exist with respect to closure of the caudal
neural tube. The posterior neuropore (PNP) was broadly open in the
targeted allele and this remained open in all homozygotes (Rifat et al.,
2010), whereas, in Grhl21Nisw mutants, the neural folds of the PNP
were elevated (Supplemental Fig. 1F and G) and we never detected a
failure of PNP closure in older Grhl21Nisw embryos. Moreover, the body
wall is apparently closed in the targeted allele, whereas the body wall
and optic ﬁssure are not closed in the ENU allele. Between the
different alleles, molecular differences are not expected. The
Grhl21Nisw allele is expected to severely truncate the protein, including
deleting the predicted CP2 DNA binding domain. Grhl2 RNA
expression in Grhl21Nisw mutant embryos when examined by in situ
hybridization appears to be localized properly and at levels compa-
rable to wild type. Using a more quantitative method, qRT-PCR,
however, there is a 2.1 fold reduction in Grhl2 mRNA in the mutant
(Table 1). The allele described by Rifat et al. (2010)(C57BL/6
background) is a targeted mutation of Grhl2 and is expected to be a
null allele, whereas the alleles studied in Werth et al. (2010) (mixed
129P2/C57BL/6 or 129/ola/C57BL/6 background) derive from gene-
traps of Grhl2 and are indicated to disrupt Grhl2 RNA and protein
expression. Therefore, it is possible that the phenotypic differences
arise from differences in genetic background. As we described above,
the genetic background affects the penetrance of the defects and age
of embryonic lethality in Grhl21Nisw mutants. At this time it is unclear
whether the phenotypic and neural hinge point differences reﬂect the
differences in the Grhl2 mutations and/or the genetic background on
which the phenotypes were examined.
Additional phenotypes in Grhl21Nisw/1Nisw mutants (but not
documented by Rifat et al., 2010 or Werth et al., 2010) include soft
tissue syndactyly, lung and heart defects. All ﬁve lobes of the lung
were present but signiﬁcantly smaller in Grhl21Nisw versus wildtype,
and this difference was clearly evident at E14.5 (Supplemental Fig. 2).
However, the appearance of the airways at E14.5 and expression of
Nkx2.1, a marker of distal lung epithelium, was relatively normal (data
not shown). By E18.5 the airways in the mutant lung were
signiﬁcantly smaller than wildtype and they look “collapsed”Fig. 2. Grhl2Nisw1 embryos show a general defect in closure of embryonic tissues and lung a
closure of the neural tube and craniofacial region compared to wildtype (WT). Side view of
with hind- to forebrain exencephaly, thoracoabdominoschisis, and soft tissue syndactyly. The
maxilla (mx, upper jaw) fails to form properly in the mutant embryos and remains as two s
NTD from hindbrain to forebrain and cleft upper face. White arrows on the mutant show the
what would be the ~normal shape of the embryo head. Front (E and F) and back (G and H) v
and neural tube. (I and J) Section from E9.5 mutant embryo stained with phalloidin, which
point to medial hinge point (MHP), both of which form in the mutant. (K–R) Skeletal staining
(O) view of the skull and frontal view of the rib cage (Q) of wildtype embryos. Side (L), top (
(S) Wildtype andmutant lungs of E14.5 embryo. (T) H&E staining of E18.5 lung of wildtype a
indicate the level of section shown in (V). so: supraoccipital, p: parietal, ip: interparietal, f:(Fig. 2T). The Grhl21Nisw heart at E18.5 appears anemic with thinner
ventricular walls and larger space within the ventricles (Fig. 2U and
V).
Patterning, proliferation and differentiation are not altered in the neural
tube of Grhl21Nisw mutants
Drosophila grainyhead acts to repress dorsal, ventral and terminal
patterning genes (Biggin and Tjian, 1988; Bray et al., 1989; Huang
et al., 1995; Liaw et al., 1995; Soeller et al., 1988), although embryos
with a null mutation in grainyhead do not display patterning defects,
likely due to maternal provision of grainyhead (Huang et al., 1995;
Liaw et al., 1995). To determine whether the neural tube closure
phenotype in Grhl21Nisw is due to a patterning defect, molecular
markers that reﬂect patterning along the anterior-posterior and
dorsal-ventral axes were examined. Whole embryo or section in situ
hybridization on E9.5 wild type and homozygous mutant embryos
showed no change in the expression pattern of Shh, Fgf8, Six3, Wnt1,
Pax3, Islet1 and Nkx2.2 or in the neural crest marker Sox10 and
differentiation at E9.5 was not altered as shown by two early neuronal
markers Islet1 and TuJ1 (Supplemental Fig. 2A–S). Proliferation was
also not affected as determined by counting the number of phospho-
Histone3 positive cells/total cell number at E8.5, E9.5 and E10.5
(Supplemental Fig. 2T; pN0.05).
Expression of genes involved in cell adhesion are affected in Grhl2
mutants
The data above together indicate that Grhl21Nisw/1Nisw mutants
cannot be distinguished fromwildtype prior to the ﬁnal step of neural
fold fusion and many of the other Grhl21Nisw phenotypes are
consistent with defects in tissue closure. This, in combination with
the putative role of adhesion molecules in closure events, led us to
hypothesize that Grhl2 transcription factor controls the expression of
one or more adhesion molecules to regulate fusion events in the
embryo.
To identify direct and indirect targets of Grhl2, we usedmicroarray
analysis to compare gene expression changes between wildtype and
mutant embryos. RNA was isolated from the head of E9.5 (23–25
somites) homozygous wildtype and homozygous mutant embryos, at
or prior to the time of neural tube closure when the neural folds innd heart defects. (A–J) homozygous Grhl21Nisw mutant (MUT) embryos show a lack of
E18.5 embryos (A and B) wildtype and mutant embryos showing the mutant is smaller
mandible (m, lower jaw) is formed in bothwild type andmutant embryos, however the
eparate processes. Side view of E11.5 (C and D) embryos showing similar body size but
extent of the neural tube opening, while the white dotted line on the mutant indicates
iew of the cranial region of E9.5 embryos showing failure of closure of the facial region
binds F-actin. Red arrows point to dorsolateral hinge points (DLHP), and white arrows
s of E18.5 wildtype and mutant embryos on C3H background. Side (K), top (M), bottom
N), bottom (P) view of the skull and frontal view of the rib cage (R) of mutant embryos.
nd mutant embryos. (U) E18.5 heart of wildtype andmutant embryo. Black dotted lines
frontal, j: jugal, na: nasal, eo: exoccipital, bo: basioccipital, bs: basisphenoid.
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neural fold elevation, patterning, etc.) and the mutant is determined
by genotyping. Affymetrix GeneChip Mouse Exon 1.0 ST microarray
experiments and bioinformatic analyses were performed by the
University of Colorado Denver Microarray core. A cutoff of 1.25-fold
difference was applied resulting in 88 genes downregulated in Grhl2
mutants (p-value b0.04 of which 54 genes had p-values b0.001) and
55 upregulated genes (p-value b0.049 of which 28 genes had p-values
b0.01). The full list of genes differentially expressed between mutant
and wild type is shown in Supplemental Tables 2 and 3. Quantitative
real-time PCR was performed on a subset of these genes and is
presented in Table 1.
Of the 40 downregulated genes with the highest fold change in the
mutant embryos, 10 encode proteins involved in adhesion (Table 2),
with a number of them within the cadherin family of adhesion
molecules, including E-cadherin (cadherin-1), cadherin 3, Desmoglein 2
and Desmocolin 2. Desmoplakin was also downregulated in Grhl21Nisw
mutants and it is indirectly involved in adhesion by mediating the
function of desmosomes. Another group of downregulated genes
encode proteins in the Claudin family: Claudin 4, Claudin 6 and Claudin
7. Claudins are components of tight junctions along with occludin and
junctional adhesion molecules. Multiple claudins are expressed in
tissue-speciﬁc manners and these proteins can form homotypic and
heterotypic interactions within the tight junction and between
adjacent cells to form an adhesive structure (Morin, 2005). Little is
known about the expression of claudins during development; thus, it
is of interest that the microarray data suggests claudins are expressed
in the cranial region at E9.5 and their expression is affected by the loss
of Grhl2.
The epithelial cell adhesion molecule (EpCAM) is a type I
transmembrane glycoprotein, with an extracellular domain contain-
ing two EGF-like repeats and a short cytoplasmic domain containing
two binding sites for α-actinin (Balzar et al., 1999). EpCAM can
abrogate E-cadherin-mediated cell–cell interactions by disrupting the
link between α-catenin and F-actin (Winter et al., 2003). EpCAM can
also form complexes with the tight junction protein claudin-7, the
variant isoform of cell–matrix adhesion protein CD44v6, and tetra-
spanin CD9, and this association facilitated metastasis (Kuhn et al.,
2007). BCam, another adhesion molecule (Rahuel et al., 1996), was
also downregulated.
Mpzl2/ Eva (Epithelial V-like antigen), a new member of the
immunoglobulin superfamily (IgSF) (Guttinger et al., 1998), was
downregulated. Mpzl2/ Eva is expressed in a variety of epithelial
tissues and is associated with distinct phases of epithelial differen-
tiation, perhaps through homophilic cell–cell adhesion (DeMonte
et al., 2007; Guttinger et al., 1998). Binding interactions between IgSF
adhesion molecules are in general weaker compared to the cadherin
family, suggesting that IgSF members mediate dynamic intercellular
adhesive interactions, rather than strong and static interactions
(Guttinger et al., 1998).Table 2
Adhesion genes downregulated in the Grhl21Nisw mutant based on microarray analysis.
Gene
symbol
Fold-change p-value
(mutant vs. WT) (mutant vs. WT)
1 Cldn4 −2.81 3.45E−06
2 E-Cdh −2.76 1.75E−05
3 Cldn6 −2.52 8.57E−05
4 Epcam −2.51 7.64E−06
5 Dsp −2.02 1.91E−05
6 Cldn7 −1.68 4.73E−06
7 Cdh3 −1.40 1.04E−04
8 Dsc2 −1.40 2.87E−04
9 Dsg2 −1.33 6.41E−04
10 Bcam −1.33 1.05E−03Themajority of the remaining downregulated genes are expressed,
exclusively or largely, in epithelial tissues. For example, Esrp1 is an
epithelial cell type-speciﬁc regulator (Warzecha et al., 2009) and
keratin8 is found in most extraembryonic and embryonic simple
epithelia, including trophectoderm, visceral yolk sac, gastrointestinal
tract, lungs, mammary glands, and uterus (Baribault et al., 1993).
Finally, Rax (retina and anterior fold protein) expression was
reduced in Grhl2mutants. Rax is expressed in the anterior neural plate
as early as E8.5 and in the optic cup starting at E9.5. Rax null mice have
forebrain defects and lack eye structures (Mathers et al., 1997).
The list of upregulated genes was shorter and the fold expression
difference less signiﬁcant. Adamts3 and Adamts1 are members of the
Adamts and Adam family of metalloproteases and they can be
membrane-anchored (Adam) or secreted (Adamts). Adamts3 can
process procollagen II and it is expressed throughout skeletal
development and in the hindbrain at E12.5 (Le Goff et al., 2006).
Adamts1 is expressed during embryogenesis, predominantly in the
epithelium of the lung, pancreas and kidney. Adamts1 null mice are
characterized by growth retardation, changes in kidney structure, and
impaired female fertility (Shindo et al., 2000). Adamts1 is also
upregulated in wounded skin and regulates migration of ﬁbroblasts
and endothelial cells (Krampert et al., 2005).
E-cadherin expression is reduced in tissues that express Grhl2
The cadherin family regulates many aspects of development
including cell adhesion, delamination and migration. E-cadherin has
been hypothesized to be involved in neural tube closure and it was one
of the most downregulated genes in our microarray experiment.
Therefore, we explored the relationship between Grhl2 and E-cadherin
expression in wildtype and mutant embryos. An RNA in situ probe
speciﬁc for Grhl2 was used to prevent detection of other Grhl family
members. At E8.5Grhl2 is expressed in the ectoderm including the non-
neural ectodermwhich overlies the neural ectoderm andwraps around
the tips of the neural folds as they come into apposition and fuse during
neural tube closure (Fig. 3A and B). Grhl3 is also expressed in the non-
neural ectoderm during these stages (Auden et al., 2006; Camerer et al.,
2010) andGrhl3 function is also required for neural tube closure asGrhl3
null mutants show 100% spina biﬁda and infrequent exencephaly (Ting
et al., 2003a), highlighting the importance of the Grhl genes in neural
tube closure in speciﬁc rostral–caudal regions (Rifat et al., 2010).
In E8.5 wildtype embryos, E-cadherin protein is expressed on the
non-neural ectoderm and wraps around the neural folds and its
localization matches the expression of Grhl2 RNA (Fig. 3C compared
to 3B). E-cadherin continues to be expressed in the ectoderm
overlying the neural tube at E9.5 and E10.5 (Fig. 3D and not shown).
In contrast, in the Grhl2 mutant at E9.5 and E10.5, E-cadherin
protein is not detectable in the non-neural ectoderm (Fig. 3E
compared to 3D; E-cadherin is also not expressed at E10.5 in the
mutant based on microarray and qRT-PCR results). As our recent
studies have shown that the non-neural ectoderm initiates fusion of
the neural folds (Pyrgaki et al., 2010), our results here combined
with the microarray results presented above provide evidence for
a role for Grhl2 in the non-neural ectoderm in the regulation of
E-cadherin expression, as well as likely other adhesion molecules, in
mediating neural fold fusion.
To determine whether Grhl2 is a key regulator of E-cadherin
expression in other epithelial tissues, we compared further the
expression of Grhl2 and E-cadherin during embryogenesis. In terms of
bodywall closure and skin development, strong expression ofGrhl2was
observed in the developing epidermis at both E14.5 and E18.5
(Supplemental Fig. 3A–D; see also Auden et al., 2006). At E18.5, Grhl2
was speciﬁcally expressed on the dermis/epidermis border and the hair
follicle (Supplemental Fig. 3C and D). In E18.5 wildtype embryos,
E-cadherin was expressed in the epidermis and hair follicles, however,
in Grhl2 mutants, E-cadherin expression was not observed in these
Fig. 3. E-cadherin is downregulated in the neural folds ofGrhl21Niswmutant. (A) Frontal cryosection of E8.5wildtype embryo following RNA in situ hybridizationwithGrhl2 probe. Grhl2 is
expressed on the non-neural ectoderm of the neural folds and the craniofacial ectoderm. (B) Detail from panel A showing the non-neural ectoderm of the neural folds. (C) E-cadherin
protein is localized to the non-neural ectoderm of the neural folds at E8.5 in a pattern that corresponds to the expression pattern ofGrhl2. (D, E) E-Cadherin is expressed on the non-neural
ectoderm of wildtype embryos (D) at E9.5whereas there is no detectable E-cadherin expression on the folds of Grhl2mutants (E). Red is E-cadherin (E-CDH); green phalloidin (PH); blue
Hoechst. All frontal sections within the midbrain. Imaging for A and B: Leica DM 5000B ﬂuorescent microscope and 10× air HC PlanApo objective, NA 0.40. D and E imaged with LSM
510META with 10× air HC PlanApo objective, NA 0.40 and C imaged with 63× oil HCX PL S-Apo objective.
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follicle shape or structure and β-catenin was normally localized
(Supplemental Fig. 3G and H), which was surprising as E-cadherin is
thought to be required for β-catenin localization on the plasma
membrane.
Grhl2 mutants also show a lung defect with smaller airways. Grhl2
RNA was detected in the epithelium of the wildtype lung at E14.5 and
E18.5 (Fig. 4A and B, respectively) and E-cadherin expression coincided
with Grhl2 in the lung epithelium (Fig. 4C). However, in Grhl21Nisw
mutants, E-cadherin, as well as β-catenin, expression was severely
downregulated compared to wildtype lung epithelium (Fig. 4D and F
compared to C and E). Ezrin, a known apical marker, was mislocalized
and/or downregulated in the epitheliumof themutant lung (Fig. 4G and
H). However, the cell shape and overall structure of the epithelial layer
was not obviously perturbed in the mutant lung. These data show that
Grhl2 in the lung epithelium is required for normal E-cadherin,
β-catenin and Ezrin expression and normal lung development.
Grhl2 is expressed in many other epithelial tissues in the mouse
embryo, as shown here and by Auden et al. (2006). Adhesion of theopposing palatal shelves is critical for palatal fusion and proper face
formation and involves several types of cell adhesion receptors.
Integrins, cadherin family members, and desmosomal components
have been found to be expressed in the prominences during face
formation or to cause craniofacial defects when absent (Bader et al.,
1998; Ferguson et al., 1992; Frebourg et al., 2006; Mogass et al., 2000;
Suzuki et al., 2000). Grhl2mutants have severe mid-facial clefting and
Grhl2 RNA was detected in the facial epithelium at E8.5, E13.5 and
E18.5 and on the olfactory epithelium, vomeronasal organ (Jacobson'
organ, E13.5) and serous glands at E13.5 and E18.5 (Fig. 3A,
Supplemental Fig. 1H and I). Grhl2 was also expressed strongly in
the gut epithelium (Supplemental Fig. 3A).
Embryonic closure is disrupted in AP-2α null embryos yet not through a
common mechanism of E-cadherin regulation
The AP-2α null mouse is one of the few other mouse mutants with
severe fusion defects (Zhang et al., 1996), yet themechanismbywhich
AP-2α acts to promote embryonic tissue closure remains unclear.
Fig. 4. Grhl2, E-cadherin, β-catenin and Ezrin expression in the lung epithelium. (A and B) Grhl2 RNA is detected in the lung epithelium at both E14.5 (A) and E18.5 (B). (C–H) E18.5
wildtype (C, E, and G) and Grhl21Nisw (D, F, and H) lungs immunostained with antibodies against E-cadherin (C, D; E-CDH), β-catenin (E and F) or Ezrin (G and H) in red; green is
phalloidin (PH). E-cadherin, β-catenin and Ezrin are all downregulated and/or mislocalized in the Grhl2 mutant lung. For A and B: Leica DM 5000B microscope and 10× air HC
PlanApo objective, NA 0.40. For C–H Imaging was performed with LSM 510META lens c-Apochromat 40×/1.2 W. C–F 1.3× zoom; G and H 2.2× zoom.
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the Grhl21Nisw and AP-2α null mutants (neural tube, body wall,
craniofacial), we examinedwhether there was a relationship between
Grhl2, AP-2α and E-cadherin. First we investigated whether Grhl2
controls AP-2α expression or vice versa. RNA in situ hybridization
shows that AP-2α is expressed normally in the Grhl21Nisw mutant
embryo and Grhl2 is expressed normally in tissues of the AP-2α null
mouse embryo (Fig. 5A–C and C′). This result correlates with the
microarray experimentswhich showedno change in AP-2α expression
in Grhl21Nisw mutants. Thus, these molecules do not regulate oneFig. 5. AP-2α null mutation does not result in E-cadherin downregulation. Frontal sections of
Grhl21Nisw mutant (B) embryos. (C and C′) Grhl2 RNA is expressed in the neural folds of AP-2
folds of wildtype (E and F) and AP-2α null mutant (G and H) E9.5 embryos (blue is Hoechst).
and with 10× air HC PlanApo objective, NA 0.40. For E–H and G′: Imaging was performed wanother's expression. We then examined whether AP-2α mutants
show a change in E-cadherin expression during embryogenesis. By
qRT-PCR for E-cadherin RNA in E9.5 wild type and AP-2α mutant
heads, we found no change in expression (p=0.4) and by immuno-
ﬂuorescencewe foundE-cadherin protein is expressed and localized in
the non-neural ectoderm overlying the neural folds of the AP-2α
mutant (Fig. 5E–H, G′). This was particularly surprising as previous
studies indicated that AP-2α binds to the promoter of E-cadherin
(Schwartz et al., 2007) and downregulation of E-cadherin expression
has been seen upon AP-2α disruption in the corneal epithelium and inE9.5 embryos. (A and B) AP-2α RNA is expressed in the neural folds of wildtype (A) and
α null mutant embryos. (E–H) E-cadherin (visualized in red) is expressed in the neural
G′ detail from G. For A–C and C′: Imaging with Leica DM 5000B ﬂuorescence microscope,
ith LSM 510META lens c-Apochromat 40×/1.2 W. E–H 1.1× zoom; and G′ 2.2× zoom.
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neural fold fusion, AP-2α does not act by regulating E-cadherin protein
expression or localization. These data indicate that Grhl2 and AP-2α
both act to mediate the little understood process of tissue closure, yet
they act by different mechanisms. This was further supported by
genetic interaction studies in which AP-2α+/− heterozygote males
were crossed with Grhl21Nisw/+ females and the resulting embryos
analyzed. Out of 34 embryos from 4 different litters, 8 embryos were
doubly heterozygous, and all of these embryos were indistinguishable
from wildtype littermates.
Discussion
Neural tube development has been an area of intense research
since the beginning of the previous century. A major goal within the
ﬁeld is to relate the knowledge acquired in various animal systems to
better understand the causes and methods of prevention of neural
tube defects in humans that occur at high frequency and with a
signiﬁcant emotional and medical impact. Despite the substantial
increase in knowledge of neural tube development, there are gaps in
our understanding of this process. The last step of neural tube
formation, joining of the neural folds, is a good example of a poorly
understood aspect of neural tube development. Moreover, there are
few animal models for the study of closure or fusion of the body wall,
optic ﬁssure and face. In this study we explored a novel mutation in
mouse that causes a general defect in embryonic tissue closure,
affecting closure of the neural tube, face, body wall, and optic ﬁssure.
From a forward genetic screen for neural tube defects, the mutant
mouse line, Line2F, was identiﬁed and found to have a wide range of
phenotypes including a general closure defect as well as abnormalities
in lung and heart development. Using a new technology of genomic
sequence capture and high-throughput sequencing of the 2.5 Mb
region associated with the Line2F phenotype, we identiﬁed an
ENU-induced point mutation in the Grhl2 gene, a transcription factor
that belongs to the Grainyhead-like (Grhl) family of proteins.
Mutations in mammalian Grhl2 have been implicated in age-related
hearing impairment in humans, although the mechanism is unknown
(Peters et al., 2002; Van Laer et al., 2008). In cancer cells, Grhl2 has
been implicated in telomerase regulation and cell proliferation
(Tanaka et al., 2008; Kang et al., 2009). However, we saw no alteration
in proliferation in the embryonic neural tube of Grhl2 mutant mouse
embryos. With respect to the function of Grhl2 during embryonic
development, our studies and recent results (Rifat et al., 2010; Werth
et al., 2010) show that loss of Grhl2 in embryos leads to neural tube
defects. In the case of the neural tube, our data indicate that formation
of hinge points is not disrupted in Grhl21Nisw mutants and neural fold
elevation and apposition occurs normally, and thus we suggest that
neural fold fusion is the critical step disrupted in Grhl21Nisw mutants.
Our results differ from those of Rifat et al. (2010) in that they report
lack of dorsolateral hinge point formation after loss of Grhl2. The
discrepancy between their ﬁndings and ours may be due to a) the
different genetic backgrounds as our results show that Grhl21Nisw
phenotypes are strain dependent and b) the use of different mutant
alleles. Our work here also extends the role of Grhl2 to show that it is
required more generally in the closure of embryonic tissues and
development of various organs. Moreover, we show that Grhl2
expression correlates well with the embryonic tissues that show a
phenotype in Grhl21Nisw mutant embryos. The discovery of the
importance of Grhl2 transcription factor in tissue morphogenesis
opens new avenues to explore the cellular and molecular basis of
these critical embryonic processes.
In the ﬁeld of neural tube development, the idea that adhesion
molecules are crucial for the process of neural fold fusion has been
widely accepted, but very little evidence provides solid support for
this idea. For example, Eph5A has been long hypothesized to regulate
the last step of neural tube closure, based on its adhesive propertiesand the fact that Eph5A null mice develop cranial neural tube defects,
but deﬁnite evidence for such involvement is lacking (Holmberg et al.,
2000). The fusion defects in the Grhl21Nisw mutant led us to
hypothesize that Grhl2 transcription factor affects the expression of
adhesion molecules during embryonic development. To explore this
hypothesis we used microarray analysis to identify direct and indirect
targets of Grhl2. Our microarray results supports the hypothesis that
Grhl2 is involved in regulation of adhesion, as many of the genes that
are misexpressed in Grhl21Nisw mutants encode proteins involved
in adhesion/epithelial function. We then speciﬁcally explored
the relationship between Grhl2 and E-cadherin and showed that
E-cadherin expression coincides with that of Grhl2 and E-cadherin
protein is downregulated in the Grhl21Nisw mutant in the tissues that
display a phenotype. The relationship between Grhl2 and E-cadherin
was also observed by Werth et al. (2010) and they showed that Grhl2
directly binds to the promoters of E-cadherin and Claudin4 (another
target identiﬁed in our microarray) to directly regulate their
transcription. Our microarray results also reveal a number of other
genes affected by the loss of Grhl2. One intriguing possibility is that
the Grhl2 transcription factor may bind to the promoter elements of a
battery of genes to coordinately regulate the expression of proteins
needed for epithelial-mediated morphogenesis. Following this rea-
soning, the spatial and temporal regulation of Grhl2 expression could
induce the expression of a cohort of targets and serve to rapidly alter
adhesion and epithelial function in a highly synchronized manner.
One of the top targets of Grhl2 revealed by the microarray
experiment was E-cadherin (cadherin1). Homozygous null mutation
of E-cadherin is not compatible with life as these embryos show severe
abnormalities before implantation (Riethmacher et al., 1995). In the
Grhl2mutant, E-cadherin expression is altered in a speciﬁc spatial and
temporal pattern. There is a striking correlation between Grhl2
expression and speciﬁc downregulation of E-cadherin expression in
those tissues that are affected in the Grhl21Nisw mutants (neural tube,
face, body wall, skin, lung). In the closing neural folds, Grhl2 and
E-cadherin are expressed on the non-neural ectoderm, which is the
single cell layer that overlies andwraps around the tip of the neural fold.
E-cadherin expression in the non-neural ectoderm is abolished in
Grhl21Nisw mutants. Our recent in vivo imaging studies have demon-
strated that the non-neural ectoderm initiates the process of neural fold
fusion (Pyrgaki et al., 2010). Chen and Hales (1995) cultured rat
embryos with an antisense oligonucleotide against E-cadherin and
showed that this led to cranial neural tube malformations (Chen and
Hales, 1995). Taken together with our results suggesting that fusion is
the defective step of neural tube development in theGrhl21Niswmutants,
we propose that disruption of Grhl2 function affects expression of
E-cadherin, as well as likely other adhesion molecules revealed by the
microarray, causing the non-neural ectoderm to lose its adhesive
capacity. This we propose results in failure of the opposing neural folds
to adhere, leading to NTD. Although it has been long hypothesized that
E-cadherin plays a crucial role in neural tube development, this is the
ﬁrst time that loss of E-cadherin from the non-neural ectoderm of the
neural folds is correlatedwith failure of the neural tube to close. Further
studies are necessary to determine whether loss of E-cadherin alone is
responsible forNTD. Indeed, our results indicate that other adhesionand
apical junctional complex molecules are also downregulated in Grhl2
mutants and therefore, it may be the combined loss of these molecules
that disrupts neural tube closure.
E-cadherin also plays an essential role in generation and mainte-
nance of epithelial cell polarity (Behrens et al., 1993; McNeill et al.,
1990). An alternate mechanism that could lead to the same NTD
outcome is that loss of Grhl2 function, with its consequent effects on
E-cadherin and other genes needed for epithelial cell function, may
disrupt the structure of the non-neural ectodermal layer so that the
cells are misoriented and/or have aberrant polarity and hence cannot
associate properly. The epithelium of the neural folds, lung and skin is
surprisingly normal in terms of cell shape and organization. In the
48 C. Pyrgaki et al. / Developmental Biology 353 (2011) 38–49mutant lung, there is a loss of E-cadherin, β-catenin, and Ezrin
expression, suggesting a defect in cell polarity and/or maintenance of
the epithelial cell layer. Indeed, the reduction in airway size may
indicate a structural defect in the lung epithelium. However, this is not
a consistent ﬁnding as in the skin and hair follicle, despite the loss of
E-cadherin, β-catenin is localized normally on the plasma membrane
of the cells and appendage structure appears normal.
Our results with the AP-2α mutant highlight the molecular
complexity of neural fold fusion. Although the closure defects in AP-2a
null andGrhl21Niswmutant embryos are strikingly similar, we found that
AP-2α and Grhl2 do not regulate one another's transcription and,
moreover, AP-2αmutants show normal expression of E-cadherin in the
neural folds whereas Grhl21Nisw mutants show loss of E-cadherin.
Moreover, trans-heterozygotes do not show evidence for genetic
interaction. The work described here demonstrates that Grhl2 directly
or indirectly regulates an extensive set of genes involved in adhesion
and epithelial function, many of whichmay contribute to the process of
neural fold fusion. In the future, it will be of interest to determine
whether AP-2α regulates a subset of these genes or whether it acts
through an independent mechanism. In this respect, recent evidence
demonstrates a critical function for protease signaling andRac1 function
from the non-neural ectoderm during neural tube closure (Camerer et
al., 2010). Our microarray data on the Grhl2mutant does not suggest an
intersection between Grhl2 and this protease network, at least at a
transcriptional level. The present study opens new avenues to explore
the commonalities and differences between the molecular pathways
regulated by protease signaling, AP-2α, and Grhl familymembers in the
closure of embryonic tissues.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.02.027.
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